Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87


Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities.

Braunstein S, Wang L, Newhauser W, Tenenholz T, Rong Y, van der Kogel A, Dominello M, Joiner MC, Burmeister J.

J Appl Clin Med Phys. 2019 Feb;20(2):7-12. doi: 10.1002/acm2.12537. Epub 2019 Feb 8. No abstract available.


An objective method to evaluate radiation dose distributions varying by three orders of magnitude.

Wilson LJ, Newhauser WD, Schneider CW.

Med Phys. 2019 Apr;46(4):1888-1895. doi: 10.1002/mp.13420. Epub 2019 Feb 23.


Tumour size can have an impact on the outcomes of epidemiological studies on second cancers after radiotherapy.

Schneider U, Walsh L, Newhauser W.

Radiat Environ Biophys. 2018 Nov;57(4):311-319. doi: 10.1007/s00411-018-0753-6. Epub 2018 Aug 31.


Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.

Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J.

Blood. 2018 Oct 18;132(16):1635-1646. doi: 10.1182/blood-2018-03-837633. Epub 2018 Aug 14. Erratum in: Blood. 2019 Mar 21;133(12):1384-1385.


Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers.

Taddei PJ, Khater N, Youssef B, Howell RM, Jalbout W, Zhang R, Geara FB, Giebeler A, Mahajan A, Mirkovic D, Newhauser WD.

Biomed Phys Eng Express. 2018;4(2). pii: 025029. doi: 10.1088/2057-1976/aaa1ce. Epub 2018 Feb 7.


Normal tissue damage: its importance, history and challenges for the future.

Williams JP, Newhauser W.

Br J Radiol. 2018 Apr 9:20180048. doi: 10.1259/bjr.20180048. [Epub ahead of print]


Impact of Multileaf Collimator Configuration Parameters on the Dosimetric Accuracy of 6-MV Intensity-Modulated Radiation Therapy Treatment Plans.

Petersen N, Perrin D, Newhauser W, Zhang R.

J Med Phys. 2017 Jul-Sep;42(3):151-155. doi: 10.4103/jmp.JMP_88_16.


Cell-shaped silicon-on-insulator microdosimeters: characterization and response to 239PuBe irradiations.

Mazza A, Newhauser W, Pittman S, Halloran A, Maggi P, Tran L, Gila B, Rosenfeld A, Ziegler J.

Australas Phys Eng Sci Med. 2017 Sep;40(3):667-673. doi: 10.1007/s13246-017-0576-9. Epub 2017 Sep 8.


A Clarion Call for Large-Scale Collaborative Studies of Pediatric Proton Therapy.

Berrington de Gonzalez A, Vikram B, Buchsbaum JC, de Vathaire F, Dörr W, Hass-Kogan D, Langendijk JA, Mahajan A, Newhauser W, Ottolenghi A, Ronckers C, Schulte R, Walsh L, Yock TI, Kleinerman RA.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):980-981. doi: 10.1016/j.ijrobp.2017.03.033. Epub 2017 Jul 10. No abstract available.


Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy.

Stokkevåg CH, Schneider U, Muren LP, Newhauser W.

Phys Med. 2017 Oct;42:259-262. doi: 10.1016/j.ejmp.2017.04.022. Epub 2017 May 13. Review. No abstract available.


A descriptive and broadly applicable model of therapeutic and stray absorbed dose from 6 to 25 MV photon beams.

Schneider CW, Newhauser WD, Wilson LJ, Schneider U, Kaderka R, Miljanić S, Knežević Ž, Stolarcyzk L, Durante M, Harrison RM.

Med Phys. 2017 Jul;44(7):3805-3814. doi: 10.1002/mp.12286. Epub 2017 Jun 1.


The Medical Physics Workforce.

Newhauser WD.

Health Phys. 2017 Feb;112(2):139-148. doi: 10.1097/HP.0000000000000614. Review.


Analytical model for ion stopping power and range in the therapeutic energy interval for beams of hydrogen and heavier ions.

Donahue W, Newhauser WD, Ziegler JF.

Phys Med Biol. 2016 Sep 7;61(17):6570-84. doi: 10.1088/0031-9155/61/17/6570. Epub 2016 Aug 17.


Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy.

Eley JG, Friedrich T, Homann KL, Howell RM, Scholz M, Durante M, Newhauser WD.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):279-86. doi: 10.1016/j.ijrobp.2016.02.032. Epub 2016 Feb 16.


A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments.

Newhauser WD, Berrington de Gonzalez A, Schulte R, Lee C.

Front Oncol. 2016 Feb 10;6:13. doi: 10.3389/fonc.2016.00013. eCollection 2016. Review.


A simple and fast physics-based analytical method to calculate therapeutic and stray doses from external beam, megavoltage x-ray therapy.

Jagetic LJ, Newhauser WD.

Phys Med Biol. 2015 Jun 21;60(12):4753-75. doi: 10.1088/0031-9155/60/12/4753. Epub 2015 Jun 4.


An analytical model of leakage neutron equivalent dose for passively-scattered proton radiotherapy and validation with measurements.

Schneider C, Newhauser W, Farah J.

Cancers (Basel). 2015 May 18;7(2):795-810. doi: 10.3390/cancers7020795.


Visualization of risk of radiogenic second cancer in the organs and tissues of the human body.

Zhang R, Mirkovic D, Newhauser WD.

Radiat Oncol. 2015 Apr 28;10:107. doi: 10.1186/s13014-015-0404-x.


Reducing the cost of proton radiation therapy: the feasibility of a streamlined treatment technique for prostate cancer.

Newhauser WD, Zhang R, Jones TG, Giebeler A, Taddei PJ, Stewart RD, Lee A, Vassiliev O.

Cancers (Basel). 2015 Apr 24;7(2):688-705. doi: 10.3390/cancers7020688.


Risk-optimized proton therapy to minimize radiogenic second cancers.

Rechner LA, Eley JG, Howell RM, Zhang R, Mirkovic D, Newhauser WD.

Phys Med Biol. 2015 May 21;60(10):3999-4013. doi: 10.1088/0031-9155/60/10/3999. Epub 2015 Apr 28.

Supplemental Content

Loading ...
Support Center